IgGenix, Inc

Developer of an antibody-based therapeutic platform intended to speed up the clinical response time against allergies. The company's platform engineers antibodies to capture allergens and endow them with powerful immune-modulating activities derived from the immunoglobulin G (IgG) antibody class, enabling the medical industry to combat life-threatening allergic reactions and cascades.

Khosla Ventures

🏥 Healthcare